Net Worth Advisory Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36,372
Closed -$46.2K 429
2026
Q1
$46.2K Hold
36,372
0.01% 436
2025
Q4
$86.9K Buy
+36,372
New +$99.5K 0.02% 439
2025
Q3
Sell
-36,543
Closed -$138K 435
2025
Q2
$138K Buy
+36,543
New +$144K 0.03% 423

Other funds holding HCAT

Net Worth Advisory Group's HCAT Position: Q2 2026 in Review

Net Worth Advisory Group sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 36,372 shares — an estimated $46.2K sold.

Net Worth Advisory Group first reported a position in HCAT in Q2 2025 and held it in 3 quarters. The position peaked at $138K in Q2 2025. 8 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Net Worth Advisory Group reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Net Worth Advisory Group sold 36,372 Health Catalyst shares in Q2 2026, an estimated $46.2K.
  • Net Worth Advisory Group first reported a position in Health Catalyst in Q2 2025 and held it in 3 quarters.
  • Net Worth Advisory Group's Health Catalyst position peaked at $138K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.